vTv Therapeutics (VTVT) Interest & Investment Income (2014 - 2026)

vTv Therapeutics has disclosed Interest & Investment Income across 13 years of filings, most recently posting $812000.0 for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 195.27% year-over-year to $812000.0; the TTM figure through Jun 2026 stood at $2.9 million (up 89.34% YoY), while the FY2025 annual figure was $1.9 million, up 19.49% from the prior year.
• Interest & Investment Income came in at $812000.0 for Q2 2026 at vTv Therapeutics, down from $838000.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $865000.0 in Q4 2025 to a low of $50000.0 in Q2 2022.
• Average Interest & Investment Income over 5 years is $347588.2, with a median of $275000.0 recorded in 2025.
• Year-over-year, Interest & Investment Income surged 387.5% in 2024 and sank 50.27% in 2025.
• Over 5 years, Interest & Investment Income stood at $152000.0 in 2022, then sank by 42.11% to $88000.0 in 2023, then surged by 387.5% to $429000.0 in 2024, then surged by 101.63% to $865000.0 in 2025, then decreased by 6.13% to $812000.0 in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $812000.0 in Q2 2026, $838000.0 in Q1 2026, and $865000.0 in Q4 2025.